09

2025-12


Public Notice of the Draft Environmental Impact Report for the Production Facility Construction Project of Minhai Biological’s Quadrivalent Inactivated Enterovirus Vaccine (Vero Cell)

I. Methods for Obtaining the Draft for Public Comment 1. Paper Version: The public may review the document at Beijing Minhai Biotechnology Co., Ltd. 2. Electronic Version: Access via the following link: https://pan.baidu.com/s/1PW6o2p5maEik3zzhazZqUA?pwd=564g; the extraction code is 564g. The public may download the document directly from this URL. II. Scope of the Public Subject to Comment The scope of this public consultation is limited to citizens and legal entities residing in the vicinity of the production workshop construction project for Minhai Biotechnology’s quadrivalent inactivated enterovirus vaccine (Vero cell) who are affected by or have concerns regarding this project.

02

2025-12


Senior executives of Kangtai Minhai have been awarded the “Outstanding Achievement Award” at the 19th Pharmaceutical Development Awards.

On November 28, 2025, the 19th Pharmaceutical Development Award Ceremony was held in Beijing. Attending the event were former State Councilor and Vice Chairperson of the Standing Committee of the 11th National People’s Congress Chen Zhili, as well as Academicians Zhang Boli, Chen Kaixian, Zhang Gaiping, Yue Jianmin, Wang Junzhi, and Xia Ningshao, along with more than 300 experts and scholars from renowned universities, research institutions, and medical organizations. Liu Jiankai, Director and Vice President of Kintor Pharmaceutical and Executive Deputy General Manager of Minhai Biotechnology, was awarded the “Outstanding Achievement Award.” The Pharmaceutical Development Award, established in 1994 under the Office of National Science and Technology Awards, recognizes contributions in the field of medicine and pharmacy.

25

2025-11


From Strategy to Execution: External Expertise Empowers Management

To comprehensively enhance the strategic thinking and operational coordination capabilities of mid- to senior-level management, thereby solidifying the managerial foundation for the company’s future development, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as “Minhai Bio”) successfully held a specialized training session on strategic operations management on November 4, 2025. The event featured renowned guest instructor Mr. Shawn, a former senior strategic management expert at Company H, who delivered an engaging lecture. Minhai Kangtai’s management team participated in an intellectual feast exploring the journey from strategy formulation to execution and implementation. With the core objectives of “deepening strategic understanding, optimizing operational processes, and reinforcing results‑oriented management,” this training aimed to provide systematic theoretical instruction and in‑depth analysis of real‑world case studies.

25

2025-11


2025 Academician and Expert Roundtable Salon: Focusing on New Breakthroughs in the Development of Hospital-Acquired Infection Vaccines

On the morning of November 15, 2025, the “2025 Academician and Expert Roundtable Salon—Vaccine Development and Challenges for Hospital-Acquired Bacterial Infections,” hosted by the Innovation Service Center of the Beijing Association for Science and Technology and co-organized by the Daxing District Association for Science and Technology, the Management Committee of the Daxing Biopharmaceutical Industry Base of the Zhongguancun Science Park, and Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as “Minhai Bio”), was successfully held at Minhai Bio’s Internationalization Industrial Base for Novel Vaccines. The event focused on the increasingly pressing global public health challenge of hospital-acquired bacterial infections (HABI), bringing together academicians of the Chinese Academy of Engineering, renowned university scholars, and national-level researchers…

06

2025-11


From Strategy to Execution: External Expertise Empowers Management

To comprehensively enhance the strategic thinking and operational coordination capabilities of mid- to senior-level management, thereby solidifying the managerial foundation for the company’s future development, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as “Minhai Bio”) successfully held a specialized training session on strategic operations management on November 4, 2025. The event featured renowned guest instructor Mr. Shawn, a former senior strategic management expert at Company H, who delivered an engaging lecture. Minhai Kangtai’s management team participated in an intellectual feast exploring the journey from strategy formulation to execution and implementation. With the core objectives of “deepening strategic understanding, optimizing operational processes, and reinforcing results‑oriented management,” this training aimed to provide systematic theoretical instruction and in‑depth analysis of real‑world case studies.

< 1234...54 >